Trials / Terminated
TerminatedNCT01223651
Performance of Continuous Glucose Monitoring Systems at Altitude
Performance of Continuous Glucose Monitoring Systems at Altitude.
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- The Royal Bournemouth Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
10 healthy volunteers will undergo the controlled lowering of their blood glucose level at sea level and a simulated altitude of 8,000 feet, to test the hypothesis that continuous glucose monitoring system measurement of blood glucose is as accurate at altitude as at sea level.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | two step hyperinsulinaemic glucose clamp study. | Study participants will have their blood glucose stabilized between 5 - 6 mmol/L by the delivering of a controlled rate insulin/glucose infusion. Participants will have their blood glucose level reduced by conducting a controlled two step hyperinsulinaemic glucose clamp. The clamp procedure will take a total of 120 minutes and will reduce the blood glucose level to below 3 mmol/L. During this time blood tests will be obtained for analysis, physical observations recorded and cognitive function tests performed at regular intervals. Participants will have been fitted at least 12 hours prior to the intervention with 2 real time continuous glucose monitoring systems which will remain in place for the duration of the clamp procedure, however participants will be blinded to their glucose readings. |
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2013-03-01
- Completion
- 2013-03-01
- First posted
- 2010-10-19
- Last updated
- 2018-09-07
Locations
2 sites across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT01223651. Inclusion in this directory is not an endorsement.